Needham Company Earns FDA Approval for Rare Disease Treatment
October 13, 2025 • After more than 10 years of work developing the drug, Stealth BioTherapeutics looks to bring Forzinity to Barth syndrome patients. In...
Planning Board Ponders “Too Big” Proposal
Aired October 6, 2022. During the third (and final) public hearing regarding the potential construction project located at 557 Highland Avenue, residents once again shared...
